Detalles de la búsqueda
1.
Nirmatrelvir, Molnupiravir, and Remdesivir maintain potent in vitro activity against the SARS-CoV-2 Omicron variant
Preprint
en Inglés
| PREPRINT-BIORXIV | ID: ppbiorxiv-476685
2.
The plasmablast response to SARS-CoV-2 mRNA vaccination is dominated by non-neutralizing antibodies that target both the NTD and the RBD
Preprint
en Inglés
| PREPRINT-MEDRXIV | ID: ppmedrxiv-21253098
3.
Intrahost evolution and forward transmission of a novel SARS-CoV-2 Omicron BA.1 subvariant
Preprint
en Inglés
| PREPRINT-MEDRXIV | ID: ppmedrxiv-22275533
4.
SARS-CoV-2 variants of concern have acquired mutations associated with an increased spike cleavage
Preprint
en Inglés
| PREPRINT-BIORXIV | ID: ppbiorxiv-455290
5.
Introductions and early spread of SARS-CoV-2 in the New York City area
Preprint
en Inglés
| PREPRINT-MEDRXIV | ID: ppmedrxiv-20056929
Resultados
1 -
5
de 5
1
Próxima >
>>